Souhaitez-vous accéder aux communiqués récents ?

Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.

Se Connecter À Un Compte Lecteur Créer Un Compte Lecteur

24 sept. 2018 16h00 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Announces Retirement of John A. Kraeutler, Executive Chairman of the Board; Appoints David C. Phillips as Chairman of the Board; and Elects Felicia Williams to the Board of Directors

CINCINNATI, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced that John (Jack) A. Kraeutler, Executive Chairman of the Board, will retire effective September...
31 juil. 2018 07h30 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Third Quarter 2018 Operating Results, Declares Regular Third Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance

CINCINNATI, July 31, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ: VIVO) today: GENERAL HIGHLIGHTS Reported record fiscal 2018 third quarter and first nine months net revenues of...
28 juin 2018 11h00 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience, Inc. Expects to Report Third Quarter Fiscal Year 2018 Operating Results on Tuesday, July 31, 2018

CINCINNATI, June 28, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading life science company, expects to release its third quarter fiscal 2018 operating results before the...
30 mai 2018 10h54 HE | Source: Meridian Bioscience Inc.

Meridian Introduces Critical Raw Materials for Nipah Virus Diagnosis, a Key Emerging Disease on the WHO’s Priority List

CINCINNATI, May 30, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today announced the availability of critical antigens and antibodies for Nipah virus immunological assay...
26 avr. 2018 07h30 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Second Quarter 2018 Operating Results, Declares Regular Second Quarter Cash Dividend, and Updates Fiscal 2018 Guidance

CINCINNATI, April 26, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: GENERAL HIGHLIGHTS Reported record fiscal 2018 second quarter and first six months net revenues of...
04 avr. 2018 10h00 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience, Inc. Expects to Report Second Quarter Fiscal Year 2018 Operating Results on Thursday, April 26, 2018

CINCINNATI, April 04, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its second quarter fiscal 2018...
21 mars 2018 07h30 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Realigns Organizational Structure

New Structure Consists of two Business Units, Diagnostics and Life Science, Supported by a Global Corporate Team Realignment Aimed at Building a Stronger, More Sustainable Organization; Paving the...
25 janv. 2018 07h15 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports First Quarter 2018 Operating Results, Declares Regular First Quarter Cash Dividend, and Reaffirms Fiscal 2018 Guidance

CINCINNATI, Jan. 25, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: GENERAL HIGHLIGHTS reported first quarter net revenues of $52.3 million, an increase of 12% from the...
19 janv. 2018 16h23 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience, Inc. Expects to Report First Quarter Fiscal Year 2018 Operating Results on Thursday, January 25, 2018

CINCINNATI, Jan. 19, 2018 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO), a leading diagnostic and life science component company, expects to release its first quarter fiscal 2018...
09 nov. 2017 07h30 HE | Source: Meridian Bioscience Inc.

Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Fourth Quarter Cash Dividend, Sets Fiscal 2018 Cash Dividend Rate, and Reaffirms Fiscal 2018 Guidance

GENERAL HIGHLIGHTS CINCINNATI, Nov. 09, 2017 (GLOBE NEWSWIRE) -- Meridian Bioscience, Inc. (NASDAQ:VIVO) today: reported fourth quarter and full-year fiscal 2017 net revenues of $49.7 million and...

Page précédente